An estimated over 900,000 Americans aged 65 and older develop Alzheimer’s disease each year. With numbers like that, many families are just wondering when the symptoms will begin. Now, researchers say a simple blood test may provide part of that answer years before memory problems appear. Scientists studying a biomarker called p-tau217 developed what they describe as an Alzheimer’s “clock” that estimates when symptoms could start, often within a three-to-four-year window of accuracy.
The findings are drawing attention because the test may eventually help doctors identify high-risk patients earlier, enroll people into prevention trials faster, and give families more time to plan financially and medically. While experts caution that the test is not ready for widespread screening of healthy adults, the research represents one of the biggest breakthroughs yet in early Alzheimer’s detection. Here’s what you need to know about this new test and when it may be available to the public.
